Moolec Science (MLECW) Shares Outstanding (2022 - 2026)
Moolec Science (MLECW) posted Shares Outstanding (Entity) of $72.6 billion for Q4 2025, up 168417.43% sequentially from $43.1 million in Q2 2025, and up 571975.29% YoY from N/an in Q4 2024.
Moolec Science (MLECW) Shares Outstanding (2022 - 2026) Analysis & Trends
Moolec Science has reported Shares Outstanding (Entity) for 4 years, with the latest figure at $72.6 billion in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 571975.29% year-over-year to $72.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $72.6 billion (up 571975.29% YoY) and the FY2025 annual result came in at $43.1 million, up 11.02% from the prior year.
- Shares Outstanding (Entity) rose to $72.6 billion in Q4 2025 per MLECW's latest filing, from $43.1 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $72.6 billion in Q4 2025 and troughed at $1.5 million in Q2 2022.
- A 4-year average of $6.1 billion and a median of $22.9 million in 2022 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) sank 41.92% in 2023, then jumped 571975.29% in 2025.
- Over 4 years, Shares Outstanding (Entity) stood at $20.7 million in 2022, then sank by 41.92% to $12.0 million in 2023, then increased by 5.5% to $12.7 million in 2024, then surged by 571975.29% to $72.6 billion in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $72.6 billion, $43.1 million, and $12.7 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Moolec Science | 8,617.72 | -1.19 Mn | - | 430,886.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 726.12 Mn |
| Dec 31, 2025 | 726.12 Mn |
| Jun 30, 2025 | 430,886.00 |
| Dec 31, 2024 | 126,927.00 |
| Sep 30, 2024 | 388,121.00 |
| Jun 30, 2024 | 388,121.00 |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 120,315.00 |
| Sep 30, 2023 | 74,070.00 |
| Jun 30, 2023 | 306,230.00 |
| Mar 31, 2023 | 250,414.00 |
| Dec 31, 2022 | 207,163.00 |
| Sep 30, 2022 | 14,652.00 |
| Jun 30, 2022 | 14,652.00 |
| Mar 31, 2022 | 206,677.00 |